Recombinant Mycobacterium bovis BCG vaccines (rBCG) were first developed in the 1990s as a means of expressing antigens from multiple pathogens. This review examines the key …
A Kilpeläinen, M Maya-Hoyos, N Saubí… - Expert Review of …, 2018 - Taylor & Francis
ABSTRACT Introduction: Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome, tuberculosis, and malaria are responsible for most human deaths produced by …
BR Kim, BJ Kim, YH Kook, BJ Kim - Frontiers in Immunology, 2019 - frontiersin.org
Mycobacterium abscessus complex (MAB) is a rapidly growing mycobacterium (RGM) whose clinical significance as an emerging human pathogen has been increasing …
BJ Kim, H Jeong, H Seo, MH Lee, HM Shin… - Frontiers in …, 2021 - frontiersin.org
At present, concerns that the recent global emergence of SARS-CoV-2 variants could compromise the current vaccines have been raised, highlighting the urgent demand for new …
H Jeong, SY Lee, H Seo, BJ Kim - Journal for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Macrophage migration inhibitory factor (MIF) is a pleotropic inflammatory cytokine that is overexpressed in a number of cancer types including most types of human …
SM Morgado, ACP Vicente - Microbial genomics, 2021 - microbiologyresearch.org
The mobilome plays a crucial role in bacterial adaptation and is therefore a starting point to understand and establish the gene flow occurring in the process of bacterial evolution. This …
Quantitative measurement of cell lysis against a given microbial strain is essential to calculate the antimicrobial potency of protein/peptide/nanomaterial based formulations …
MH Lee, HL Kim, H Seo, S Jung, BJ Kim - Journal of Biomedical Science, 2023 - Springer
Background Mycobacterium tuberculosis is the causative agent of tuberculosis (TB), and its pathogenicity is associated with its ability to evade the host defense system. The secretory …
BJ Kim, BR Kim, YH Kook, BJ Kim - Frontiers in immunology, 2018 - frontiersin.org
Even though the rate of new human immunodeficiency virus type 1 (HIV-1) infections is gradually decreasing worldwide, an effective preventive vaccine for HIV-1 is still urgently …